HomeCompareBSDGF vs PFE

BSDGF vs PFE: Dividend Comparison 2026

BSDGF yields 6.96% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BSDGF wins by $43015.32M in total portfolio value
10 years
BSDGF
BSDGF
● Live price
6.96%
Share price
$0.52
Annual div
$0.04
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43015.37M
Annual income
$41,859,468,989.04
Full BSDGF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BSDGF vs PFE

📍 BSDGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBSDGFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BSDGF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BSDGF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BSDGF
Annual income on $10K today (after 15% tax)
$591.33/yr
After 10yr DRIP, annual income (after tax)
$35,580,548,640.68/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, BSDGF beats the other by $35,580,526,320.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BSDGF + PFE for your $10,000?

BSDGF: 50%PFE: 50%
100% PFE50/50100% BSDGF
Portfolio after 10yr
$21507.71M
Annual income
$20,929,747,623.88/yr
Blended yield
97.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BSDGF
No analyst data
Altman Z
5.9
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BSDGF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBSDGFPFE
Forward yield6.96%6.13%
Annual dividend / share$0.04$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$43015.37M$49.6K
Annual income after 10y$41,859,468,989.04$26,258.71
Total dividends collected$42935.93M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BSDGF vs PFE ($10,000, DRIP)

YearBSDGF PortfolioBSDGF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$12,091$1,391.36$9,153$693.39+$2.9KBSDGF
2$16,082$3,144.57$8,593$849.25+$7.5KBSDGF
3$25,026$7,817.73$8,336$1,066.78+$16.7KBSDGF
4$49,516$22,738.72$8,437$1,384.80+$41.1KBSDGF
5$137,078$84,095.50$9,013$1,875.40+$128.1KBSDGF
6$581,823$435,149.13$10,306$2,680.72+$571.5KBSDGF
7$4,074,840$3,452,289.43$12,820$4,101.38+$4.06MBSDGF
8$49,553,307$45,193,228.65$17,673$6,826.70+$49.54MBSDGF
9$1,080,285,199$1,027,263,160.60$27,543$12,591.86+$1080.26MBSDGF
10$43,015,374,152$41,859,468,989.04$49,560$26,258.71+$43015.32MBSDGF

BSDGF vs PFE: Complete Analysis 2026

BSDGFStock

Bosideng International Holdings Limited researches, designs, develops, manufactures, markets, and distributes branded down apparel products, original equipment manufacturing (OEM) products, and non-down apparel products in the People's Republic of China. The company operates through four segments: Down Apparels, OEM Management, Ladieswear Apparels, and Diversified Apparels. It engages in the business of sourcing and distributing branded down and ladieswear apparels; and non-seasonal apparels, including branded menswear, school uniform, and children's wear. The company provides down apparel products under the Bosideng, Snow Flying, Bengen, etc. brands; ladies wear products under the JESSIE, BUOU BUOU, KOREANO, and KLOVA brands; and school uniforms under the Sameite brand. It also offers network consulting and e-business of down and non-down apparel; logistics and storage services; and brand design and development services, as well as operates as an advertisement agency. As of March 31, 2022, it operated 462 ladieswear retail outlets; 364 self-operated retail outlets; and 98 retail outlets operated by third party distributors. Bosideng International Holdings Limited was founded in 1976 and is based in Central, Hong Kong.

Full BSDGF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BSDGF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BSDGF vs SCHDBSDGF vs JEPIBSDGF vs OBSDGF vs KOBSDGF vs MAINBSDGF vs JNJBSDGF vs MRKBSDGF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.